Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have shown for the first time that a gene usually linked to giant axonal neuropathy, a rare and severe neurological condition, also plays a role in inhibiting ...
Feb 29, 2024
0
10
A two-year follow-up clinical trial found that a new personalized cellular therapy treatment for relapsed or refractory B-cell lymphoma demonstrated strong safety and improved overall survival in patients, according to findings ...
Feb 27, 2024
0
0
Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system. However, when pancreatic cancer develops, its cells also need vitamin B6 to replicate. During the ensuing tug-of-war over ...
Feb 23, 2024
0
2
A study led by the group of Didier Trono at EPFL has revealed a crucial survival tactic employed by cancer cells. The scientists have identified a group of proteins, known as "KRAB zinc finger proteins" (KZFPs), that help ...
Feb 12, 2024
0
0
As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients can benefit from groundbreaking therapies. In work published ...
Feb 5, 2024
0
0
Nearly four years into the pandemic, Australia, like many other countries, is still seeing large numbers of COVID cases. Some 860,221 infections were recorded around the country in 2023, while 30,283 cases have already been ...
Jan 23, 2024
0
0
A new study sheds light on how autophagy, the body's process for removing damaged cell parts, when impaired, can play a role in causing heart failure.
Jan 11, 2024
0
2
Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell therapy, is cost-effective for second-line diffuse large B-cell lymphoma (DLBCL) therapy, according to a study published online Dec. 28 in Blood ...
Jan 4, 2024
0
0
Patients with lupus nephritis (LN), a severe complication of systemic lupus erythematosus (SLE), often undergo progressive kidney damage, with approximately 20% of these patients advancing to end-stage renal disease.
Dec 13, 2023
0
0
An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: A nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles ...
Dec 12, 2023
0
0
